Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Calorie restriction vs. the obesity paradox
- BMI and mortality in elderly patients (1)
- BMI and mortality in elderly patients (2)
- Inherited DNA variants & longevity
- GWAS: fathers age at death
- Genetic risk scores and parents’ longevity
- Biomarkers
- Studying molecular biomarkers
- Adding linked lab work to build causal evidence
- Conclusions - learning points
Topics Covered
- Examples: calorie restriction vs. the obesity paradox, inherited DNA variants and longevity
Talk Citation
Melzer, D. (2016, December 28). Studying aging in humans 2 - practice [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/TBVZ7281.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. David Melzer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Studying aging in humans 2 - practice
Published on December 28, 2016
20 min
Other Talks in the Series: Aging
Transcript
Please wait while the transcript is being prepared...
0:00
Hello again
to this second part of my talk
on studying human aging.
As trailed at the end of the first part,
I'm going to discuss three examples
in order to help you
apply the lessons you've learned
from the methodological issues
we discussed in the first half
of this talk.
0:24
Now I'd like, in the next few slides,
to give you three examples
to draw together
some of the themes that we've discussed
around in the way aging develops
and the challenges of measuring
aging in humans
and the challenges
of undertaking robust study designs.
Now the first example
is about calorie restriction.
Now calorie restriction in animals,
restricting their diet to such an extent
that they remain healthy
and have a balanced diet
and have very little adiposity.
That has been shown repeatedly
to increase longevity
in most mouse models.
I'm sure this will be covered
in some of the other talks
in this course.
It's very clear from mouse experiments
that being lean increases survival.
And the same is pretty true in humans,
that is,
humans in the normal weight range,
so a body mass index from 18.5 to 25
have lower mortality than those
who are overweight or obese in midlife,
and obesity and being overweight
clearly increases mortality
and a whole range of disease
processes midlife.
However,
there's a major apparent paradox
of obesity in later life.
For example, Flegal et al.,
meta-analyzed a huge number
of studies of obesity
and reported that grade 1 obesity,
that's body mass indexes
between 30 and 35
overall were associated
with high mortality
in 65-year-olds and older.
How is it possible
that the experimental data
shows that obesity is bad for you
and the observational data
in later life shows the opposite?